tiprankstipranks
Elevate Uranium Ltd (AU:EL8)
ASX:EL8
Want to see AU:EL8 full AI Analyst Report?

Elevate Uranium Ltd (EL8) AI Stock Analysis

28 Followers

Top Page

AU:EL8

Elevate Uranium Ltd

(Sydney:EL8)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
AU$0.22
▼(-4.78% Downside)
Action:Reiterated
Date:06/04/26
The score is primarily constrained by weak financial performance (ongoing losses and negative cash flows) despite a stable, low-leverage balance sheet. Technicals are only mildly supportive with neutral oscillators but a negative MACD and price still below longer-term moving averages. Valuation is also penalized because the company is loss-making (negative P/E) and has no stated dividend yield.
Positive Factors
Low Leverage Balance Sheet
A conservative capital structure with low debt reduces refinancing and interest pressure over the medium term. This preserves financial flexibility to fund exploration or tolerate cyclical delays, supporting project advancement without immediate solvency risk.
Negative Factors
Persistent Losses and Cash Burn
Ongoing negative EBIT and net losses mean the business lacks internal profitability to fund exploration or development. Continued cash burn forces reliance on external financing, which can dilute shareholders or delay project timelines if capital markets tighten.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage Balance Sheet
A conservative capital structure with low debt reduces refinancing and interest pressure over the medium term. This preserves financial flexibility to fund exploration or tolerate cyclical delays, supporting project advancement without immediate solvency risk.
Read all positive factors

Elevate Uranium Ltd (EL8) vs. iShares MSCI Australia ETF (EWA)

Elevate Uranium Ltd Business Overview & Revenue Model

Company Description
Headquartered in West Perth, Australia, Elevate Uranium Ltd focuses on the exploration and evaluation of uranium reserves, a business it has pursued since its incorporation in 1978. The company's key operations are distributed across two main regi...
How the Company Makes Money
null...

Elevate Uranium Ltd Financial Statement Overview

Summary
Revenue improved, but the company remains unprofitable with negative net income/EBIT and continued cash burn (negative operating and free cash flow). The balance sheet is a relative strength due to low leverage, but negative ROE highlights ongoing losses.
Income Statement
25
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue768.50K768.50K182.000.000.000.00
Gross Profit813.11K768.50K-121.67K-117.68K-85.52K-54.29K
EBITDA-11.03M-11.85M-10.62M-8.51M-5.68M-2.66M
Net Income-10.99M-12.32M-10.75M-8.63M-5.73M-2.60M
Balance Sheet
Total Assets45.64M25.46M13.26M12.54M19.33M9.96M
Cash, Cash Equivalents and Short-Term Investments36.65M21.71M10.83M10.06M15.81M6.66M
Total Debt390.56K432.41K74.21K146.03K177.27K99.29K
Total Liabilities1.52M1.57M1.48M1.02M838.59K429.54K
Stockholders Equity44.12M23.89M11.78M11.52M18.49M9.53M
Cash Flow
Free Cash Flow-13.74M-11.71M-9.31M-5.90M-4.49M-2.40M
Operating Cash Flow-13.27M-11.62M-9.24M-5.83M-4.38M-2.33M
Investing Cash Flow-3.50M-714.24K-73.79K-74.52K-137.62K-61.28K
Financing Cash Flow23.13M23.22M10.09M158.86K13.67M7.99M

Elevate Uranium Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.23
Price Trends
50DMA
0.24
Positive
100DMA
0.26
Positive
200DMA
0.29
Negative
Market Momentum
MACD
<0.01
Negative
RSI
69.02
Neutral
STOCH
93.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:EL8, the sentiment is Positive. The current price of 0.23 is below the 20-day moving average (MA) of 0.25, below the 50-day MA of 0.24, and below the 200-day MA of 0.29, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 69.02 is Neutral, neither overbought nor oversold. The STOCH value of 93.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:EL8.

Elevate Uranium Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
51
Neutral
AU$783.45M-346.85-0.94%70.28%
49
Neutral
AU$4.83B-64.29-3.90%
49
Neutral
AU$117.24M-9.74-17.88%41.33%
49
Neutral
AU$1.46B914.710.29%-100.00%
47
Neutral
AU$139.06M-2.74-10.95%-32.93%
45
Neutral
AU$131.79M-10.34-32.33%37.27%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:EL8
Elevate Uranium Ltd
0.26
-0.03
-10.34%
AU:PDN
Paladin Energy Ltd
10.40
4.06
64.04%
AU:AEE
Aura Energy
0.11
-0.05
-31.25%
AU:BMN
Bannerman Energy
3.80
1.36
55.74%
AU:DYL
Deep Yellow Limited
1.53
0.07
4.81%
AU:PEN
Peninsula Energy
0.28
-0.18
-38.60%

Elevate Uranium Ltd Corporate Events

Elevate Uranium Lifts Marenica Stake to 90% and Issues Cleansing Notice
Jul 29, 2026
Elevate Uranium Ltd has issued 4,701,659 fully paid ordinary shares as part of the consideration to acquire an additional 10% stake in Marenica Minerals, the owner of the Marenica Uranium Project in Namibia. This transaction increases Elevate Uran...
Elevate Uranium lifts Marenica stake as pilot plant optimisation continues
Jul 28, 2026
Elevate Uranium reported ongoing optimisation of its U-pgradeTM pilot plant in Namibia, where an expanded technical team is working to refine processing units and establish consistent baseline operations. The company warned that pilot plant result...
Elevate Uranium Extends Settlement Timeline for Marenica Share Purchase
Jul 28, 2026
Elevate Uranium Ltd has updated its disclosure on a proposed issue of securities linked to its acquisition of a further 5 percent stake in Marenica Minerals Pty Ltd. The company has notified the ASX that the closing date for settlement of this rem...
Elevate Uranium Seeks ASX Quotation for 4.7 Million New Shares
Jul 28, 2026
Elevate Uranium Ltd has applied to the ASX for quotation of 4,701,659 new ordinary fully paid shares, which were issued on July 28, 2026. The additional securities, linked to a previously announced transaction, will expand the company&#8217;s list...
Elevate Uranium lifts Marenica stake to 90% as Namibia portfolio grows
Jul 28, 2026
Elevate Uranium has increased its ownership of the Marenica Uranium Project in Namibia to 90 percent through two transactions, issuing 4,701,659 shares and paying $1.1 million in cash to acquire an additional 10 percent stake, while extending the ...
Elevate Uranium Plans New Share Issue to Strengthen Capital Base
Jul 12, 2026
Elevate Uranium Ltd has lodged a notice with the ASX outlining a proposed issue of up to 9,333,900 ordinary fully paid shares under a placement or similar capital-raising structure. The new securities, expected to be issued on 31 July 2026, will b...
Elevate Uranium lifts Marenica resource as Namibian development programs advance
Jun 9, 2026
Elevate Uranium has announced an updated mineral resource estimate for its Marenica Uranium Project in Namibia, lifting the total resource to 52.8 million pounds of U3O8 at a grade of 180 ppm. The increase follows infill drilling of previously ide...
Elevate Uranium shareholders back capital raisings and incentive plan at general meeting
May 8, 2026
Elevate Uranium shareholders have approved all resolutions put forward at the company&#8217;s 8 May 2026 general meeting, with each motion passed by poll. The outcomes ratify a recent placement of shares, confirm the issue of shares to Core Lithiu...
Elevate Uranium Trims Future Equity Pool as Options and Rights Lapse
May 6, 2026
Elevate Uranium Ltd has announced the lapse of several classes of equity-based instruments, including 140,000 options expiring in September 2028, 413,686 performance rights, and 500,769 options expiring in October 2029, after the conditions attach...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 04, 2026